Microsoft buys genetic data software from Merck

RSS

Wall Street Journal, June 3, 2009

Microsoft continued its push into healthcare through a deal with Merck to gain access to some genetic data-management software. Microsoft plans to incorporate the genetic and genomic data-management software into Microsoft Amalga Life Sciences. Amalga is part of a push by Microsoft, whose other offerings include patient health-records holder HealthVault, to become a bigger player in healthcare.

Full Story

Healthcare Creates 1 in 5 New Jobs

Healthcare employment is about the only bright spot in an otherwise drab U.S. Bureau of Labor Statistics report on job growth in August.

Spine experts repudiate Medtronic studies

In an extraordinary move, a group of spine specialists are publicly repudiating the research of other experts that has backed the widespread use of a Medtronic bone growth product. In a series of reports...

Health IT contracts offer little protection for buyers

As healthcare providers purchase electronic health record software and other health IT to meet meaningful use requirements, they must insist that the legal contracts they sign with vendors will protect their...

Book: The Hospital Executive's Guide to Emergency Department Management

With 50-70 percent of hospital admissions coming through the emergency department, it’s the key driver of profitability for your hospital--and where community opinion about your...

go to complete list